NCT01278030View on ClinicalTrials.gov

Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

June 30, 2012

Conditions
Heart Failure
Interventions
PROCEDURE

3D echo-guided LV lead placement

Information about left ventricular mechanical dyssynchrony and the location of the site of latest mechanical activation based on RT3DE will be available to the physician from the core lab analysis. This location will be used as the target for optimal LV lead placement.

Trial Locations (1)

Unknown

The Heart Group, Nashville

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01278030 - Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates | Biotech Hunter | Biotech Hunter